What is a Sleeping Draught?
A sleeping draught is an archaic term for a liquid medication or potion intended to induce sleep, historically used before modern pharmaceutical sleep aids became available.
Historical Context and Modern Equivalents
The term "sleeping draught" originates from older medical and literary traditions, referring to liquid preparations—often herbal tinctures, alcohol-based solutions, or early sedative compounds—consumed to promote sleep. This terminology appears in historical medical texts and literature (such as Shakespeare's works) but has been replaced in contemporary medicine by specific pharmacologic classifications 1.
Modern Pharmacologic Sleep Aids
In current clinical practice, the concept of a "sleeping draught" has evolved into FDA-approved hypnotic medications for insomnia disorder, which include:
First-Line Pharmacologic Options (when indicated)
- Benzodiazepine receptor agonists (BzRAs): eszopiclone, zolpidem
- Orexin receptor antagonists: suvorexant
- Low-dose sedating antidepressants: doxepin
These agents may improve short-term global and sleep outcomes for adults with insomnia disorder 2, though evidence quality is generally low and trials were predominantly small and short-term.
Critical Clinical Caveats
Safety Concerns
Modern "sleeping draughts" (hypnotics) carry significant risks that the historical term obscures:
- Cognitive and behavioral changes, including driving impairment 2
- Increased risk for dementia, fractures, and major injury in observational studies 2
- FDA-mandated dose reductions in women and older adults due to safety concerns 2
Evidence Limitations
- Comparative effectiveness between agents remains unknown 2
- Long-term efficacy data are lacking 2
- Most evidence is insufficient or low strength, particularly for older adults 2
Contemporary Clinical Approach
Cognitive behavioral therapy for insomnia (CBT-I) is recommended as first-line treatment before any pharmacologic intervention 3. Pharmacotherapy should only be considered through shared decision-making when CBT-I proves inadequate 3.
The romanticized notion of a "sleeping draught" belies the complexity and potential harms of modern sleep medications, which require careful patient selection, monitoring, and typically short-term use only.